Debrisoquine oxidation phenotype and susceptibility to lung cancer.

Eitemau Tebyg

• Debrisoquine oxidation phenotype and susceptibility to lung cancer.
  gan: Boobis, A R, et al.
  Cyhoeddwyd: (1990)
• Attempts to phenotype human liver samples in vitro for debrisoquine 4-hydroxylase activity.
  gan: Boobis, A R, et al.
  Cyhoeddwyd: (1985)
• Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.
  gan: Speirs, C J, et al.
  Cyhoeddwyd: (1986)
• The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype.
  gan: Caporaso, N E, et al.
  Cyhoeddwyd: (1992)
• Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.
  gan: Davies, D S, et al.
  Cyhoeddwyd: (1981)